| 英文别名： |
Rifamycin S;1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin;Rifampicin S;rifomycin S;(12S,3E,5S,13E,15Z)-7t-acetoxy-15,9c,11t-trihydroxy-5r-methoxy-12,4,6t,8c,10c,12t,16-heptamethyl-2-oxa-18-aza-1(2,7)-naphtho[2,1-b]furana-cyclooctadecaphane-3,13,15-triene-11,6,9,17-tetraone;1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin;EINECS 236-938-4;NCI 144-130;O1,O4-didehydro-rifamycin;Rifamycin,1,4-dideoxy-1,4-dihydro-1,4-dioxo;rifamycin-S;rifaximin S;rifomycin-S;UNII-PI53N820JV;Rifaximin EP Impurity E;Rifaximin impurity E (EP);4-dideoxy-1,4-dihydro-1,4-dioxo-rifamycin;Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo-;5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-21-aceta;rifomycins;nci144-130;RIFAMYCIN S;RIFAMPICIN S;1,4-dideoxy-1,4-dihydro-1,4-dioxo-rifamycin;s4425;MFCD06198807;PI53N820JV;13553-79-2;DTXSID301043935;NSC 144130;RIFAMYCIN S [EP IMPURITY];RIFAXIMIN IMPURITY E [EP IMPURITY];RIFAMYCIN SODIUM IMPURITY B [EP IMPURITY];((2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,17,19-TRIHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,6,9,11-TETRAOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENAZANO)NAPHTHO(2,1-B)FURAN-21-YL ACETATE;Rafamycin S;Rifomycin S;NSC144130;SCHEMBL415695;Q27116328;[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate;2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate;BTVYFIMKUHNOBZ-ODRIEIDWSA-N;CHEMBL236921;BRN 0604802;CHEBI:34948;RIFAMYCIN S [MI];NSC-144130 |
沪公网安备 
